Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
07/2001
07/03/2001US6254646 Oxidizing composition and uses for dyeing, permanently setting or bleaching keratin fibres
06/2001
06/28/2001WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis
06/28/2001WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
06/28/2001WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
06/28/2001WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
06/28/2001WO2000051545A3 Hair care compositions
06/27/2001EP1110953A1 Quinazoline derivatives
06/27/2001EP1110949A1 EP4 receptor selective agonists in the treatment of osteoporosis
06/27/2001EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
06/27/2001EP1109537A1 Immediate release tablet
06/27/2001EP1109527A2 Cosmetic composition
06/27/2001CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
06/27/2001CN1301166A Steroidal saponins for treating alzheimer's disease
06/27/2001CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
06/27/2001CN1301164A New treatment for nervous disorders
06/27/2001CN1301160A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract
06/26/2001US6251916 For therapy of pain
06/26/2001US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
06/26/2001US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis
06/26/2001US6251436 Drug preparations for treating sexual dysfunction
06/26/2001US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution
06/26/2001US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts
06/26/2001US6251145 Enzyme of 2-electron oxidoreductase type in the presence of at least one donor for the said enzyme; cationic polymer
06/22/2001CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis
06/21/2001WO2001044291A2 Polynucleotid encoding the rg1 polypeptide
06/21/2001WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
06/21/2001WO2001043709A1 Hair bleaching and colouring compositions having a ph greater than ph 10 comprising cholesterol
06/21/2001US20010003851 Hair colorant composition containing phytantriol
06/21/2001CA2394574A1 Dna encoding a novel rg1 polypeptide
06/21/2001CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases
06/20/2001EP1108417A2 Hair colorant composition
06/20/2001EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors
06/20/2001CN1300303A Enzyme inhibitors
06/20/2001CN1300213A Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof
06/20/2001CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
06/20/2001CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis
06/20/2001CN1299973A HCV-free-blood external preparing method
06/20/2001CN1299643A Beauty method for making skin white
06/19/2001US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
06/19/2001CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
06/14/2001WO2001042252A1 New aminopropylphosphinic acids
06/14/2001WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS
06/14/2001WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone
06/14/2001WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
06/14/2001US20010003749 Arylpiperazines having activity at the serotonin 1A receptor
06/14/2001CA2393470A1 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
06/13/2001EP1105152A1 Tnf-derived peptides for use in treating oedema
06/13/2001EP1105145A1 Method and pharmaceutical composition for reducing serum homocysteine concentration
06/13/2001EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body
06/13/2001CN1299367A 2''-deoxy hygromycin derivatives
06/13/2001CN1299365A Hygromycin A derivatives
06/13/2001CN1299249A Reagent for tumor therapy and/or imaging
06/13/2001CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor
06/12/2001US6245811 Fatty acid esters as bioactive compounds
06/12/2001US6245745 Bactericides and antiprotozoa agents
06/12/2001CA2060384C A pharmaceutical composition containing an antibody recognizing the cdw52 antigen
06/07/2001WO2001039784A1 Pancreatic stem cells and their use in transplantation
06/07/2001WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide
06/07/2001CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide
06/07/2001CA2392615A1 Pancreatic stem cells and their use in transplantation
06/06/2001EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
06/06/2001EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists
06/06/2001CN1298294A Nicotine inhaler
06/06/2001CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use
06/05/2001US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid
06/05/2001US6241988 Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations
06/05/2001US6241976 With continuous phase containg water-immiscible liquid carrier and gel-forming structurant, disperse phase which is solution of antiperspirant active in water, optional solvent
05/2001
05/31/2001WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/31/2001WO2001038310A1 2-arylquinoline derivatives, preparation and therapeutic use thereof
05/31/2001WO2001037848A1 Mixture of pomegranate seed oil and juice products
05/31/2001WO2001037845A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001WO2001003683A3 Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts
05/31/2001WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts
05/31/2001US20010002290 Comprising allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectant
05/31/2001US20010002260 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same
05/31/2001CA2392369A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/31/2001CA2392149A1 2-arylquinoline derivatives, preparation and therapeutic use thereof
05/31/2001CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/31/2001CA2389537A1 Mixture of pomegranate seed oil and juice products
05/30/2001EP1103251A1 Use of 1,1-dioxoperhydro-1,2,4-thiadiazines
05/30/2001EP1102747A1 Crystalline forms of osanetant
05/30/2001EP1102584A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/30/2001EP0859582B1 Strengthening agent
05/30/2001CN1297478A Compositions comprising viruses and methods for concentrating virus preparations
05/30/2001CN1297449A Novel 2-heterocyclically substd. dihydropyrimidines
05/30/2001CN1297356A Matrix protein compositions for wound healing
05/30/2001CN1297351A Intermittent claudication therapeutic drugs comprising pyrroloazepines
05/29/2001US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring
05/29/2001US6239135 Arylpiperazines having activity at the serotonin 1A receptor
05/29/2001US6239113 Topical treatment or prevention of ocular infections
05/29/2001US6238664 Process for stabilizing proteins
05/29/2001US6238647 Anticholinergic medicament which is selected from the group consisting of ipratropium, atropine, oxitropium and salts thereof
05/29/2001CA2325778A1 Use of 1,1-dioxoperhydro-1,2,4-thiadiazines
05/25/2001WO2001036001A2 Interferon gamma conjugates
05/25/2001CA2390292A1 Interferon gamma conjugates
05/24/2001US20010001659 Inorganic sunscreen agent such as titanium dioxide, an anioic emulsifier, a carrier oil and at least one emollient; high sun protection factor without whitening effects
05/23/2001CN1296488A Bicycle hydroxamic acid derivatives